Cargando…
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?
Autores principales: | Siebert, Stefan, Millar, Neal L, McInnes, Iain B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691857/ https://www.ncbi.nlm.nih.gov/pubmed/30297330 http://dx.doi.org/10.1136/annrheumdis-2018-213654 |
Ejemplares similares
-
IL-23 orchestrating immune cell activation in arthritis
por: Najm, Aurélie, et al.
Publicado: (2021) -
Without a trace: Why did corona apps fail?
por: White, Lucie, et al.
Publicado: (2021) -
Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammation
por: Wright, Pamela B., et al.
Publicado: (2016) -
Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail?
por: Persson, Torbjörn, et al.
Publicado: (2014) -
IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
por: Baeten, Dominique, et al.
Publicado: (2021)